Paper33767151
Viral infection of cells within the tumor microenvironment mediates antitumor immunotherapy via selective TBK1-IRF3 signaling.
Brown MC and 12 others. Nat Commun, 2021. Cited by 58 papers, by iCite.
Cite this record
ConductScience Library. Viral infection of cells within the tumor microenvironment mediates antitumor immunotherapy via selective TBK1-IRF3 signaling. Papers, record 33767151. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33767151
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics20
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Breast Neoplasms | Major topic |
| Interferon Regulatory Factor-3 | Major topic |
| Melanoma | Major topic |
| Oncolytic Virotherapy | Major topic |
| Protein Serine-Threonine Kinases | Major topic |
| Tumor Microenvironment | Major topic |
| Animals | |
| CD8-Positive T-Lymphocytes | |
| Female | |
| Humans | |
| Immunity, Innate | |
| Interferon Type I | |
| Interferon-Induced Helicase, IFIH1 | |
| Lymphocytes, Tumor-Infiltrating | |
| Mice | |
| Mice, Inbred C57BL | |
| Mice, Knockout | |
| NF-kappa B | |
| Signal Transduction | |
| Th1 Cells |
Source PubMed
Grants8
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R35 CA197264 | NCI NIH HHS | United States | R35CA197264 | PubMed and NIH | NIH RePORTER |
| R35 CA225622 | U.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI) | P01CA225622 | PubMed and NIH | NIH RePORTER | |
| T32 GM136627 | NIGMS NIH HHS | United States | T32GM136627 | PubMed | NIH RePORTER |
| K08 CA237726 | NCI NIH HHS | United States | K08CA237726 | PubMed and NIH | NIH RePORTER |
| P01 CA225622 | NCI NIH HHS | United States | P01CA225622 | PubMed and NIH | NIH RePORTER |
| F32 CA224593 | NCI NIH HHS | United States | F32CA224593 | PubMed and NIH | NIH RePORTER |
| P30 CA014236 | NCI NIH HHS | United States | P30CA014236 | PubMed | NIH RePORTER |
| R01 NS108773 | NINDS NIH HHS | United States | R01NS108773 | PubMed and NIH | NIH RePORTER |
References57
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 18029230 | Signaling to NF-kappaB by Toll-like receptors. | Trends Mol Med | 2007 | https://conductscience.org/library/papers/18029230 | PubMed |
| 2 | 25187541 | Induction of viral, 7-methyl-guanosine cap-independent translation and oncolysis by mitogen-activated protein kinase-interacting kinase-mediated effects on the serine/arginine-rich protein kinase. | J Virol | 2014 | https://conductscience.org/library/papers/25187541 | PubMed |
| 3 | 14673093 | Antigen-driven effector CD8 T cell function regulated by T-bet. | Proc Natl Acad Sci U S A | 2003 | https://conductscience.org/library/papers/14673093 | PubMed |
| 4 | 12447360 | Memory and flexibility of cytokine gene expression as separable properties of human T(H)1 and T(H)2 lymphocytes. | Nat Immunol | 2003 | https://conductscience.org/library/papers/12447360 | PubMed |
| 5 | 26027717 | Type I interferons in anticancer immunity. | Nat Rev Immunol | 2015 | https://conductscience.org/library/papers/26027717 | PubMed |
| 6 | 9182680 | T cell stimulation in vivo by lipopolysaccharide (LPS). | J Exp Med | 1997 | https://conductscience.org/library/papers/9182680 | PubMed |
| 7 | 26973881 | Glioblastoma-infiltrated innate immune cells resemble M0 macrophage phenotype. | JCI Insight | 2016 | https://conductscience.org/library/papers/26973881 | PubMed |
| 8 | 22704623 | Timing and magnitude of type I interferon responses by distinct sensors impact CD8 T cell exhaustion and chronic viral infection. | Cell Host Microbe | 2012 | https://conductscience.org/library/papers/22704623 | PubMed |
| 9 | 28886381 | Oncolytic Virotherapy Promotes Intratumoral T Cell Infiltration and Improves Anti-PD-1 Immunotherapy. | Cell | 2017 | https://conductscience.org/library/papers/28886381 | PubMed |
| 10 | 28486109 | Tumor-Residing Batf3 Dendritic Cells Are Required for Effector T Cell Trafficking and Adoptive T Cell Therapy. | Cancer Cell | 2017 | https://conductscience.org/library/papers/28486109 | PubMed |
| 11 | 25959818 | Direct Activation of STING in the Tumor Microenvironment Leads to Potent and Systemic Tumor Regression and Immunity. | Cell Rep | 2015 | https://conductscience.org/library/papers/25959818 | PubMed |
| 12 | 20079668 | Interferons direct Th2 cell reprogramming to generate a stable GATA-3(+)T-bet(+) cell subset with combined Th2 and Th1 cell functions. | Immunity | 2010 | https://conductscience.org/library/papers/20079668 | PubMed |
| 13 | 24048120 | Tissue-resident macrophages. | Nat Immunol | 2013 | https://conductscience.org/library/papers/24048120 | PubMed |
| 14 | 8658169 | Induction of bystander T cell proliferation by viruses and type I interferon in vivo. | Science | 1996 | https://conductscience.org/library/papers/8658169 | PubMed |
| 15 | 19016445 | The isolation and characterization of murine macrophages. | Curr Protoc Immunol | 2008 | https://conductscience.org/library/papers/19016445 | PubMed |
| 16 | 19307177 | Use of the pharmacological inhibitor BX795 to study the regulation and physiological roles of TBK1 and IkappaB kinase epsilon: a distinct upstream kinase mediates Ser-172 phosphorylation and activation. | J Biol Chem | 2009 | https://conductscience.org/library/papers/19307177 | PubMed |
| 17 | 21930769 | Type I interferon is selectively required by dendritic cells for immune rejection of tumors. | J Exp Med | 2011 | https://conductscience.org/library/papers/21930769 | PubMed |
| 18 | 24521472 | An optimized protocol for human M2 macrophages using M-CSF and IL-4/IL-10/TGF-β yields a dominant immunosuppressive phenotype. | Scand J Immunol | 2014 | https://conductscience.org/library/papers/24521472 | PubMed |
| 19 | 23580529 | Persistent LCMV infection is controlled by blockade of type I interferon signaling. | Science | 2013 | https://conductscience.org/library/papers/23580529 | PubMed |
| 20 | 1846972 | Transgenic mice susceptible to poliovirus. | Proc Natl Acad Sci U S A | 1991 | https://conductscience.org/library/papers/1846972 | PubMed |
Cited by46
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 58 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42985438 | Viruses in the tumor immune microenvironment: implications for immunotherapy. | Front Immunol | 2026 | https://conductscience.org/library/papers/42985438 | PubMed |
| 41993267 | Viral Microglia Reprogramming Clears Oligomeric Neurotoxic Debris. | bioRxiv | 2026 | https://conductscience.org/library/papers/41993267 | PubMed |
| 41835051 | Hydrogel Micro/Nanostructures for the Delivery of Oncolytic Viruses: Overcoming Limitations and Improving Efficacy. | Adv Pharm Bull | 2025 | https://conductscience.org/library/papers/41835051 | PubMed |
| 41756179 | Combination of oncolytic viruses and immune checkpoint inhibitors for treatment of high-grade gliomas. | Front Neurol | 2026 | https://conductscience.org/library/papers/41756179 | PubMed |
| 41613791 | The Frontier of Melanoma Treatment: Defeating Immunotherapy Resistance-A Systematic Review. | Oncol Res | 2026 | https://conductscience.org/library/papers/41613791 | PubMed |
| 41311391 | Targeting pattern recognition receptors for cancer therapy: Mechanisms and strategies. | Acta Pharm Sin B | 2025 | https://conductscience.org/library/papers/41311391 | PubMed |
| 41270238 | Lymphotropic Virotherapy Induces DC and High Endothelial Venule Inflammation, Promoting the Antitumor Efficacy of Intratumor Virus Administration. | Cancer Immunol Res | 2026 | https://conductscience.org/library/papers/41270238 | PubMed |
| 40736577 | REGγ regulates antiviral response by activating TBK1-IFNβ signaling through degradation of PPP2CB. | Cell Mol Life Sci | 2025 | https://conductscience.org/library/papers/40736577 | PubMed |
| 40626649 | Polio virotherapy provokes MDA5 signaling and CD4+ T cell help to mediate cancer in situ vaccination. | Microbiol Mol Biol Rev | 2025 | https://conductscience.org/library/papers/40626649 | PubMed |
| 40484646 | Targeting TBK1 potentiates oncolytic virotherapy via amplifying ICAM1-mediated NK cell immunity in chemo-resistant colorectal cancer. | J Immunother Cancer | 2025 | https://conductscience.org/library/papers/40484646 | PubMed |
| 40280970 | Repurposing anti-viral subunit and mRNA vaccines T cell immunity for intratumoral immunotherapy against solid tumors. | NPJ Vaccines | 2025 | https://conductscience.org/library/papers/40280970 | PubMed |
| 40148688 | Deciphering permissivity of human tumor ecosystems to oncolytic viruses. | Oncogene | 2025 | https://conductscience.org/library/papers/40148688 | PubMed |
| 39320053 | Peripheral Blood IFN Responses to Toll-Like Receptor 1/2 Signaling Associate with Longer Survival in Men with Metastatic Prostate Cancer Treated with Sipuleucel-T. | Cancer Res Commun | 2024 | https://conductscience.org/library/papers/39320053 | PubMed |
| 39272146 | Circ_0001947 encapsulated by small extracellular vesicles promotes gastric cancer progression and anti-PD-1 resistance by modulating CD8+ T cell exhaustion. | J Nanobiotechnology | 2024 | https://conductscience.org/library/papers/39272146 | PubMed |
| 39161768 | TBK1 is paradoxical in tumor development: a focus on the pathway mediating IFN-I expression. | Front Immunol | 2024 | https://conductscience.org/library/papers/39161768 | PubMed |
| 39120310 | Intratumoral Microbiome: Foe or Friend in Reshaping the Tumor Microenvironment Landscape? | Cells | 2024 | https://conductscience.org/library/papers/39120310 | PubMed |
| 38689623 | Focus on current and emerging treatment options for glioma: A comprehensive review. | World J Clin Oncol | 2024 | https://conductscience.org/library/papers/38689623 | PubMed |
| 38272925 | Interplay between ATRX and IDH1 mutations governs innate immune responses in diffuse gliomas. | Nat Commun | 2024 | https://conductscience.org/library/papers/38272925 | PubMed |
| 38183802 | Elucidating cellular response to treatment with viral immunotherapies in pediatric high-grade glioma and medulloblastoma. | Transl Oncol | 2024 | https://conductscience.org/library/papers/38183802 | PubMed |
| 37771912 | Intratumor microbiome: selective colonization in the tumor microenvironment and a vital regulator of tumor biology. | MedComm (2020) | 2023 | https://conductscience.org/library/papers/37771912 | PubMed |
Genes48
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/33767151
GET https://conductscience.org/api/papers/v1/33767151/references?page=2